JP7727383B2 - 合成組織対照及び合成組織マイクロアレイ対照の細胞収率 - Google Patents

合成組織対照及び合成組織マイクロアレイ対照の細胞収率

Info

Publication number
JP7727383B2
JP7727383B2 JP2020501427A JP2020501427A JP7727383B2 JP 7727383 B2 JP7727383 B2 JP 7727383B2 JP 2020501427 A JP2020501427 A JP 2020501427A JP 2020501427 A JP2020501427 A JP 2020501427A JP 7727383 B2 JP7727383 B2 JP 7727383B2
Authority
JP
Japan
Prior art keywords
cells
cell culture
cultured
cancer
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020501427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515287A (ja
JP2020515287A5 (cg-RX-API-DMAC7.html
Inventor
イマム、サイード、アシュラフ
リース、マーク、リー.
Original Assignee
エスエルエムピー、エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エスエルエムピー、エルエルシー filed Critical エスエルエムピー、エルエルシー
Publication of JP2020515287A publication Critical patent/JP2020515287A/ja
Publication of JP2020515287A5 publication Critical patent/JP2020515287A5/ja
Priority to JP2024165854A priority Critical patent/JP2025000752A/ja
Application granted granted Critical
Publication of JP7727383B2 publication Critical patent/JP7727383B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36—Embedding or analogous mounting of samples
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00—Supports or coatings for cell culture characterised by topography
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N2001/2893—Preparing calibration standards
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36—Embedding or analogous mounting of samples
    • G01N2001/368—Mounting multiple samples in one block, e.g. TMA [Tissue Microarrays]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
JP2020501427A 2017-03-22 2018-03-22 合成組織対照及び合成組織マイクロアレイ対照の細胞収率 Active JP7727383B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024165854A JP2025000752A (ja) 2017-03-22 2024-09-25 合成組織対照及び合成組織マイクロアレイ対照の細胞収率

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/466,421 US20180275027A1 (en) 2017-03-22 2017-03-22 Cell yield for synthetic tissue controls and synthetic tissue microarray controls
US15/466,421 2017-03-22
PCT/US2018/023840 WO2018175774A1 (en) 2017-03-22 2018-03-22 Cell yield for synthetic tissue controls and synthetic tissue microarray controls

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024165854A Division JP2025000752A (ja) 2017-03-22 2024-09-25 合成組織対照及び合成組織マイクロアレイ対照の細胞収率

Publications (3)

Publication Number Publication Date
JP2020515287A JP2020515287A (ja) 2020-05-28
JP2020515287A5 JP2020515287A5 (cg-RX-API-DMAC7.html) 2021-04-15
JP7727383B2 true JP7727383B2 (ja) 2025-08-21

Family

ID=63583360

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020501427A Active JP7727383B2 (ja) 2017-03-22 2018-03-22 合成組織対照及び合成組織マイクロアレイ対照の細胞収率
JP2024165854A Pending JP2025000752A (ja) 2017-03-22 2024-09-25 合成組織対照及び合成組織マイクロアレイ対照の細胞収率

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024165854A Pending JP2025000752A (ja) 2017-03-22 2024-09-25 合成組織対照及び合成組織マイクロアレイ対照の細胞収率

Country Status (7)

Country Link
US (1) US20180275027A1 (cg-RX-API-DMAC7.html)
EP (1) EP3601644A4 (cg-RX-API-DMAC7.html)
JP (2) JP7727383B2 (cg-RX-API-DMAC7.html)
CN (1) CN110651073A (cg-RX-API-DMAC7.html)
AU (2) AU2018240361A1 (cg-RX-API-DMAC7.html)
CA (1) CA3057612A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018175774A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3126713A1 (fr) * 2021-09-08 2023-03-10 Erypharm Procédé de production de cellules de culture à haute densité
WO2024010921A1 (en) * 2022-07-08 2024-01-11 Slmp, Llc Bioengineered and standardized human tissue reference controls for validation of ihc, fish or cish cancer test results

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016535591A (ja) 2013-10-21 2016-11-17 ヘモシアー・リミテッド・ライアビリティ・カンパニーHemoShear, LLC 腫瘍微細環境のための試験管内モデル

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153132A (en) * 1988-06-30 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional co-culture process
US5851816A (en) * 1988-06-30 1998-12-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Cultured high-fidelity three-dimensional human urogenital tract carcinomas and process
US6190657B1 (en) * 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
EP2221361A3 (en) * 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US6828111B2 (en) * 2000-01-13 2004-12-07 Wayne State University Three-dimensional in vitro model of human preneoplastic breast disease
CN101186899A (zh) * 2007-10-18 2008-05-28 天津医科大学 一种应用于肿瘤细胞和干细胞共培养的新方法
WO2010067904A1 (ja) * 2008-12-12 2010-06-17 国立大学法人東京大学 細胞の3次元階層的共培養法
GB201100180D0 (en) * 2011-01-06 2011-02-23 Capsant Neurotechnologies Ltd Tumour cell and tissue culture
CN103571792B (zh) * 2012-07-25 2015-11-18 中国科学院大连化学物理研究所 一种体外扩增肿瘤干细胞的方法
US9932559B2 (en) * 2012-11-16 2018-04-03 The Johns Hopkins University Platform for creating an artificial blood brain barrier
US20170307615A1 (en) * 2014-09-24 2017-10-26 Geisinger Health System Immunohistochemistry Quality Management Program Using Cultured Cell Lines for Tissue Microarray (TMA) Blocks
US10329623B2 (en) * 2015-08-28 2019-06-25 Slmp, Llc Synthetic tissue controls and synthetic tissue microarray controls

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016535591A (ja) 2013-10-21 2016-11-17 ヘモシアー・リミテッド・ライアビリティ・カンパニーHemoShear, LLC 腫瘍微細環境のための試験管内モデル

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J Histochem Cytochem., 2016年07月, 発行日, Vol.64, No.7, pp.403-411
Sci Rep., 2017年01月30日, 発行日, Vol.7, No.41160, pp.1-12

Also Published As

Publication number Publication date
JP2020515287A (ja) 2020-05-28
EP3601644A4 (en) 2020-12-16
CA3057612A1 (en) 2018-09-27
WO2018175774A1 (en) 2018-09-27
AU2018240361A1 (en) 2019-10-31
CN110651073A (zh) 2020-01-03
US20180275027A1 (en) 2018-09-27
AU2023203396A1 (en) 2023-06-29
JP2025000752A (ja) 2025-01-07
AU2023203396B2 (en) 2025-11-20
EP3601644A1 (en) 2020-02-05

Similar Documents

Publication Publication Date Title
JP2025000752A (ja) 合成組織対照及び合成組織マイクロアレイ対照の細胞収率
Rego et al. The facultative heterochromatin of the inactive X chromosome has a distinctive condensed ultrastructure
Packeisen et al. Demystified… tissue microarray technology
TW200811295A (en) Systems and methods for efficient collection of single cells and colonies of cells and fast generation of stable transfectants
US10197569B1 (en) In vitro homogenous cell block, method of making and using
McCray et al. Handling and assessment of human primary prostate organoid culture
Dannhorn et al. Morphological and molecular preservation through universal preparation of fresh-frozen tissue samples for multimodal imaging workflows
CN109415702A (zh) 细胞培养
Eguíluz et al. Multitissue array review: a chronological description of tissue array techniques, applications and procedures
US11906405B2 (en) Methods and systems for preparing cytological samples
Chen et al. Multidimensional coculture system to model lung squamous carcinoma progression
CN107144456B (zh) 一种石蜡病理切片组织的水凝胶支撑和脂质清除处理方法
US20240018452A1 (en) Chip for integrated tumor cell behavior experiments
US10329623B2 (en) Synthetic tissue controls and synthetic tissue microarray controls
Lavickova et al. Integrated Microfluidic Platform for High‐Throughput Generation of Intestinal Organoids in Hydrogel Droplets
Nielsen et al. Detection of lncRNA by LNA-based in situ hybridization in paraffin-embedded cancer cell spheroids
HK40019730A (en) Cell yield for synthetic tissue controls and synthetic tissue microarray controls
JP2006300667A (ja) 包埋支持剤の固定固化器具及び生物試料の保持方法並びにテッシュアレイヤーゲル
Saremi et al. Application of tissue microarray in esophageal adenocarcinoma
Zhao et al. A novel in-situ fixation and embedding method improves lung cancer organoid histopathology
CN117965449A (zh) 一种结直肠癌类器官的制备方法
Nunes et al. Cell Microarray: An Approach to Evaluate Drug-Induced Alterations in Protein Expression
CN113970472A (zh) 组织切片方法以及用于组织切片的成型装置
US20240167923A1 (en) Bioengineered and standardized Human Tissue Reference Controls for Validation of IHC, FISH or CISH Cancer Test Results
Zhu et al. Optimized pregelatinized starch technique for cell block preparation in cell cultures

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210303

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220513

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220906

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230105

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20230117

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240713

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240815

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250415

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250808

R150 Certificate of patent or registration of utility model

Ref document number: 7727383

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150